Novartis Settles Texas Medicaid Fraud Claim Involving Elidel
It was announced on October 30, 2012 by the Texas Attorney General that the Swiss pharmaceutical company Novartis has agreed to pay $19.9 million to settle a civil Medicaid fraud enforcement action by the State of Texas and the U.S. government that alleged that it illegally marketed for “of[...]